13F-HR filed by Blue Owl Capital Holdings LP
Blue Owl Capital Holdings LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-15, with 41 holding rows worth $359,560,578.
- Accession
- 0000950123-24-008845
- Filer
- CIK 1858703
- Filed
- 2024-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 43 entries on the cover page, a total value of $359,560,578 stated on the cover page (in dollars after the unit check, H1), rows summing to $359,560,578 with VALUE read as dollars as filed, 13F file number 028-21866. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBlue Owl Credit Advisors LLC
- included managerBlue Owl GPSC Advisors LLC
- included managerBlue Owl Technology Credit Advisors LLC
- included managerBlue Owl GPSC IV Advisors LLC
- included managerBlue Owl Credit Private Fund Advisors LLC
- included managerBlue Owl Healthcare Opportunities Advisors LLC
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 2,049,172 | $35,737,560 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 3,004,199 | $32,295,139 | dollars as filed | |
| BLUE OWL CAPITAL CORPORATION COM | 69121K104 | CEF | 2,045,070 | $31,412,275 | dollars as filed | |
| KLAVIYO INC COM SER A | 49845K101 | Stock | 1,198,270 | $29,824,940 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 3,859,468 | $27,981,143 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 2,449,827 | $23,101,869 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 1,715,401 | $22,060,057 | dollars as filed | |
| EVERCOMMERCE INC | 29977X105 | COMMON STOCK | 1,641,929 | $18,028,381 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 2,926,028 | $12,903,783 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 3,372,499 | $11,129,247 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 268,238 | $11,024,582 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 5,161,290 | $10,348,386 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 215,260 | $9,701,768 | dollars as filed | |
| TOASTINCCLASSCLASSA | 888787108 | STOK | 322,578 | $8,312,835 | dollars as filed | |
| E2OPEN PARENT HOLDINGS INC | 29788T103 | COM CL A | 1,650,943 | $7,412,734 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 157,633 | $7,203,828 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 4,091,118 | $6,750,345 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 1,673,877 | $5,724,659 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 450,339 | $5,268,966 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 95,000 | $5,035,950 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,120,027 | $4,995,320 | dollars as filed | |
| STARWOOD PPTY TR INC COM | 85571B105 | REIT | 226,456 | $4,289,077 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 1,046,025 | $3,462,343 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 897,809 | $3,232,112 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 1,140,000 | $2,964,000 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 2,829,712 | $2,829,712 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 733,568 | $2,318,075 | dollars as filed | |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 1,055,882 | $2,185,676 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 55,000 | $2,159,850 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 80,000 | $2,112,000 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 340,855 | $1,758,812 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 40,000 | $1,675,600 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 65,000 | $1,064,700 | dollars as filed | |
| BLEND LABS INC | 09352U108 | CL A | 361,587 | $853,351 | dollars as filed | |
| GOHEALTH INC | 38046W204 | CL A NEW | 83,264 | $814,631 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M113 | W EXP 10/31/2028 | 51,177 | $608,301 | dollars as filed | |
| PLUM ACQUISITION CORP III | G63290129 | UNIT 03/31/2028 | 70,000 | $324,001 | dollars as filed | |
| DESKTOP METAL INC | 25058X303 | COMMON STOCK | 750,000 | $309,750 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 20,220 | $196,741 | dollars as filed | |
| GERON CORP | 374163103 | COM | 23,918 | $101,412 | dollars as filed | |
| Plum Acquisition Corp. III | G63290103 | Warrant | 666,666 | $46,667 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-24-008845 | this filing | 2024-08-15 | acceptance time not in the bulk data set |